Q Fever Global Market Prognosticated To Perceive A Thriving Growth; MRFR Unleashes Industry Insights Up To 2023; Marketresearchfuture.com

MarketResearchFuture.com published a Half-Cooked research report on “Global Q Fever Market Research Report – Forecast to 2023” reports to its database. – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2023.

You can get easy access to samples from the report here: https://www.marketresearchfuture.com/sample_request/5490 .

The global Q fever market is expected to grow at a CAGR of 6.3% during the forecasted period

Market Highlights:

The infection caused by the bacterium Coxiella burnetii is termed as Q fever. Usually, Q fever is a mild disease with flu-like symptoms. Many patients have no symptoms at all while in some cases; the infection can reoccur/resurface years later. The chronic Q fever is a more deadly form of Q fever which may damage heart, liver, brain, lungs and can cause diabetes in some cases.

The global Q fever market is expecting a steady growth during the forecasted period. Growing geriatric population, increasing prevalence of infectious diseases, and technological advancement in surgery have driven the market growth. Moreover, increasing healthcare expenditure, and rising demand for the better treatment have fueled the growth of the market. However, lack of awareness about the disease in developing economies and poor reimbursement policies in developed countries may slow the growth of this market.

Taste the market data and market information presented through more than 115 market data tables and figures spread over 105 pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Q fever market research report–Global forecast till 2023.”

Key Players:

Some of the key players in Q fever market are Yashica Pharmaceuticals Private Limited (India) Merck & Co. (U.S.), Atox Bio (Israel), Teva Pharmaceutical Industries (Israel), Basilea Pharmaceutica Ltd. (Switzerland), and MELINTA THERAPEUTICS, INC. (U.S.), Pfizer (U.S.), Cipla Inc. (India), and others.

Intended Audience:

• Pharmaceutical Manufacturers and Suppliers
• Medical Research Laboratories
• Research and Development (R&D) Companies
• Market Research and Consulting Service Providers
• Potential Investors

Segments:              

The global Q fever market is segmented on the basis of type, diagnosis, treatment, and end users.

On the basis of the type, the market is categorized into acute Q fever and chronic Q fever.

On the basis of the diagnosis, the market is segmented into imaging tests, blood test, and others. The imaging test is further sub-segmented into echocardiography, X-ray, and others.

Based on the treatment, the market is segmented into antibiotic and surgery

On the basis of the end users, the market is segmented into hospitals & clinics, diagnostic centers, surgical centers, and others.

Regional Analysis:

The Americas account for the largest share in the global Q fever market owing to the presence of key players in the market and rising emphasis on diagnosis and treatment of rare diseases. Furthermore, the rising awareness about bacterial infection further accelerates the growth of the market. North America is the accounted for the highest market share in this region with the U.S. being the largest market followed by Canada. In the U.S, the prevalence of cardiovascular disease is found to be increasing from last few years. This is attributed to the rising prevalence of chronic diseases such as obesity and diabetes which are major risk factors for cardiovascular diseases. As per the Center for Disease Control & Prevention (CDC), in 2015, 28.4 million adults were diagnosed with cardiovascular diseases in the U.S. alone.

Europe is the second largest market and holds a noticeable share in the global Q fever market. The European market is expected to grow significantly during the forecast period owing to the availability of advanced treatment facilities, skilled medical professionals. Furthermore, extensive research and development activities for the treatment of rare disease, and increasing government support boosts the market growth.

Asia Pacific is expected to be the fastest growing market. Increasing prevalence of chronic diseases such as diabetes, cancer and bacterial infection in developing countries is the major driver for the market growth. China and India are the fastest growing regions owing to an increasing geriatric population. Also, the bacterial infection is one of the major chronic conditions affecting a large number of patients, thereby influencing the market growth. Rising awareness about the infections and availability of new treatment methods drive the market in this region. Rising healthcare expenditure and overall growth of healthcare diagnostic and treatment industry also drive the market. According to the International Diabetic Federation, about 415 million people had diabetes across the globe in 2015, which is expected to reach 642 million by 2040. It also stated that 98.4 million and 65.1 million diabetic population lived in China and India, respectively. It stated that in 2015, 3.7% of the Asian population was diagnosed with chronic heart disease, while 21% of the people had hypertension.

The Middle East & Africa is expected to show the least growth in the market due to some major factors such as lack of awareness about the Q fever, limited access and availability of treatment facilities. In the Middle East, the United Arab Emirates has the largest market share owing to the development of healthcare industry and rising availability of specialty care centers.

Major TOC of Q Fever Market:

Chapter 1.    Report Prologue

Chapter 2.    Market Introduction

Chapter 3.    Research Methodology

Chapter 4.    Market Dynamics

Chapter 5.    Market Factor Analysis

Chapter 6.    Global Q Fever Market, By Type

Chapter 7.    Global Q Fever Market, By Diagnosis

Chapter 8.    Global Q Fever Market, By Treatment

Chapter 9.    Global Q Fever Market, By End User

Chapter 10.    Global Q Fever Market, By Region

Chapter 11.    Company Landscape

Chapter 12.    Company Profiles

Chapter 13.    MRFR Conclusion

Chapter 14.    Appendix

LIST OF TABLES:

Table 1        Q Fever Industry Synopsis, 2017-2023

Table 2        Global Q Fever Market Estimates And Forecast, 2017-2023, (USD Million)

Table 3        Global Q Fever Market By Region, 2017-2023, (USD Million)

Table 4        Global Q Fever Market By Types, 2017-2023, (USD Million)

Table 5        Global Q Fever Market By Diagnosis, 2017-2023, (USD Million)

LIST OF FIGURES:

Figure 1    Research Process

Figure 2    Segmentation For Global Q Fever Market

Figure 3    Segmentation Market Dynamics For Q Fever Market

Figure 4    Global Q Fever Market Share, By Diagnosis 2016

Figure 5    Global Q Fever Market Share, By Treatment 2016

…CONTINUED FOR TOC

Feel free to get in touch for discounts and customized details:https://www.marketresearchfuture.com/check-discount/5490 .

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact: 
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com